55
Views
0
CrossRef citations to date
0
Altmetric
Management Perspective

Reducing mortality from colorectal cancer: screening versus primary prevention

Pages 425-434 | Published online: 19 Nov 2014

References

  • Siegel R , WardE, BrawleyO, JemalA. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin.61, 212–236 (2011).
  • Scholefield JH , MossSM, ManghamCM, WhynesDK, HardcastleJD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut6, 1036–1040 (2012).
  • Atkin WS , EdwardsR, Kralj-HansIet al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet375, 1624–1633 (2010).
  • Schoen RE , PinskyPF, WeissfeldJLet al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N. Engl. J. Med.366, 2345–2357 (2012).
  • Segnan N , ArmaroliP, BonelliLet al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial – SCORE. J. Natl Cancer Inst.103, 1310–1322 (2011).
  • Hoff G , GrotmolT, SkovlundE, BretthauerM. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. Brit. Med. J.338, b1846 (2009).
  • Holme O , BretthauerM, FretheimA, Odgaard-JensenJ, HoffG. Felxible sigmoidoscopy versus occult blood testing for colorectal cance screening in asymptomatic individuals. Cochrane Database Syst. Rev.9, CD009259 (2013).
  • Nishihara R , WuK, LochheadPet al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N. Engl. J. Med.369, 1095–1105 (2013).
  • Whyte S , ChilcottJ, CooperKet al. Re-appraisal of the options for colorectal cancer screening. Report for the NHS Bowel Cancer Screening Programme (2011). www.screening.nhs.uk/policydb_download.php?doc=130
  • Sharp L , TilsonL, WhyteSet al. Cost–effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunotesting and flexible sigmoidoscopy. Brit. J. Cancer106, 805–816 (2012).
  • Shaukat A , MonginSJ, GeisserMSet al. Long-term mortality after screening for colorectal cancer. N. Engl. J. Med.369, 1106–1114 (2013).
  • Stat fact sheets: colon and rectal cancer. Surveillance, epidemiology and end results programme (SEER) . National Cancer Institute USA. http://seer.cancer.gov/statfacts/html/colorect.html
  • Marmot MG , AltmanDG, CameronDA, DewarJA, ThompsonSG, WilcoxM. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. A report jointly commissioned by Cancer Research UK and the Department of Health (England) October 2012. Br. J. Cancer108, 2205–2240 (2013).
  • Baum M . The Marmot report: accepting the poisoned chalice. Br. J. Cancer108, 2198–2199 (2013).
  • Ilic D , NeubergerNM, DjulbegovicM, DahmP. Screening for prostate cancer. Cochrane Database Syst. Rev.1, CD004720 (2013).
  • The National Lung Screening Trial Research Team . Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med.365, 395–409 (2011).
  • Zauber AG , WinawerSJ, O’BrienMJet al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N. Engl. J. Med.366, 687–696 (2012).
  • Rosenthal E . The $2.7 Trillion Medical Bill. Colonoscopies explain why US leads the world in health expenditure. NY Times, 2 June, 2013. www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html?_r=0
  • Doll R , PetoR. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst.66, 1191–1308 (1981).
  • Platz EA , WillettWC, ColditzGA, RimmEB, SpiegelmanD, GiovannucciE. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control11, 579–588 (2000).
  • Vargas AJ , ThompsonPA. Diet and nutrient factors in colorectal cancer risk. Nutr. Clin. Pract.27, 613–623 (2012).
  • Slattery ML , CaanBJ, PotterJDet al. Dietary energy sources and colon cancer risk. Am. J. Epidemiol.145, 199–210 (1997).
  • Murray CJL , LopezAD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet349, 1498–1504 (1997).
  • Key TJ , ApplebyPN, SpencerEA, TravisRC, RoddamAW, AllenNE. Cancer incidence in vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford). Am. J. Clin. Nutr.89, S1620–S1626 (2009).
  • Ryder SD , JacynaMR, LeviAJ, RizziPM, RhodesJM. Eating peanuts increases rectal proliferation in individuals with mucosal expression of peanut lectin receptor. Gastroenterology114, 44–49 (1998).
  • Evans RC , FearS, AshbyDet al. Diet and colorectal cancer: an investigation of the lectin/galactose hypothesis. Gastroenterology122, 1784–1792 (2002).
  • Aune D , ChanDSM, LauRet al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. Brit. Med. J.343, d6617 (2011).
  • Pan M-H , LaiC-S, WuJ-C, HoC-T. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol. Nutr. Food Res.55, 32–45 (2011).
  • Qin J , LiR, RaesJet al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature464, 59–65 (2010).
  • Proctor LM . The human microbiome project in 2011 and beyond. Cell Host Microbe10, 287–291 (2011).
  • Human Microbiome Project Consortium . Structure, function and diversity of the healthy human microbiome. Nature486, 207–214 (2012).
  • Sears CL , GarrettWS. Microbes, microbiota, and colon cancer. Cell Host and Microbe15, 317–328 (2014).
  • Greten FR , EckmannL, GretenTFet al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell118, 285–296 (2004).
  • Rakoff-Nahoum S , MedzhitovR. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science317, 124–127 (2007).
  • Zhu Q , GaoR, WuW. Qin Huanlong. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumor Biol.34, 1285–1300 (2013).
  • Russell WR , GratzSW, DuncanSHet al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr.93, 1062–1072 (2011).
  • Bardou M , BarkunAN, MartelM. Obesity and colorectal cancer. Gut62, 933–947 (2013).
  • Ermund A , SchütteA, JohanssonME, GustafssonJK, HanssonGC. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. Am. J. Physiol. Gastrointest. Liver Physiol.305, G341–G347 (2013).
  • Johansson ME , GustafssonJK, Holmén-LarssonJet al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut63, 281–291 (2014).
  • Swidsinski A , KhilkinM, KerjaschkiDet al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology115, 281–286 (1998).
  • Martin HM , CampbellBJ, HartCAet al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology127, 80–93 (2004).
  • Cuevas-Ramos G , PetitCR, MarcqI, BouryM, OswaldE, NougayrèdeJP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl Acad. Sci. USA107, 11537–11542 (2010).
  • Arthur JC , Perez-ChanonaE, MühlbauerMet al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science338, 120–123 (2012).
  • Buc E , DuboisD, SauvanetPet al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS  ONE8(2), e56964 (2013).
  • Prorok-Hamon M , FriswellMK, AlswiedAet al. Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut63, 761–770 (2014).
  • Bonnet M , BucE, SauvanetPet al. Colonization of the human gut by E. coli and colorectal cancer risk. Clin. Cancer Res.20, 859–67 (2014).
  • Roberts CL , KeitaAV, ParsonsBNet al. Soluble plantain fibre blocks adhesion and M-cell translocation of intestinal pathogens. J. Nutr. Biochem.24, 97–103 (2013).
  • Parsons BN , WigleyP, SimpsonHLet al. Dietary supplementation with soluble plantain non-starch polysaccharides inhibits intestinal invasion of salmonella typhimurium in the chicken. PLoS ONE9(2), e87658 (2014).
  • NHS Choices: five-a-day: what counts? www.nhs.uk/Livewell/5ADAY/Pages/Whatcounts.aspx
  • Nichols M , TownsendN, Luengo-FernandezRet al. European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis (2012). www.escardio.org/about/documents/eu-cardiovascular-disease-statistics-2012.pdf
  • Nabel EG , BraunwaldE. A tale of coronary artery disease and myocardial infarction. New. Engl. J. Med.366, 54–63 (2012).
  • Whyte S , ChilcottJ, HalloranS. Reappraisal of the options for colorectal cancer screening in England. Colorectal Dis.14, e547–e561 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.